FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1513821330> ?p ?o ?g. }

• W1513821330 endingPage "554" @default.
• W1513821330 startingPage "548" @default.
• W1513821330 abstract "Survival outcomes for patients with osteosarcoma have remained stagnant over the past 30 years. Targeting of ganglioside GD2, a glycosphingolipid on the cell surface of some tumors, with immunotherapy has resulted in improved outcomes for patients with neuroblastoma. In the current study, the expression pattern of GD2 was examined in osteosarcoma.Immunohistochemistry was performed on osteosarcoma samples from patients at the time of initial biopsy, definitive surgery, and disease recurrence. The intensity and location of staining were scored. Cell-based enzyme-linked immunoadsorbent assay was performed on osteosarcoma cell lines to quantitate the level of GD2 expression.Forty-four osteosarcoma samples were evaluated by immunohistochemistry, including 8 samples from the initial biopsy, 28 samples from the definitive surgery, and 8 samples from the time of disease recurrence. GD2 was expressed on all 44 osteosarcoma samples. Osteosarcoma tissue obtained at the time of disease recurrence demonstrated a higher intensity of staining compared with samples obtained at initial biopsy and definitive surgery (P = .016). The majority of osteosarcoma cell lines expressed GD2 at higher levels than the neuroblastoma cell line BE(2)-C.Ganglioside GD2 is highly expressed on osteosarcomas. Clinical trials are needed to assess the efficacy of targeting GD2 in patients with osteosarcoma." @default.
• W1513821330 created "2016-06-24" @default.
• W1513821330 creator A5015087487 @default.
• W1513821330 creator A5032743242 @default.
• W1513821330 creator A5044457816 @default.
• W1513821330 creator A5052668402 @default.
• W1513821330 creator A5053864071 @default.
• W1513821330 creator A5055067235 @default.
• W1513821330 creator A5057392248 @default.
• W1513821330 creator A5064538521 @default.
• W1513821330 date "2013-10-25" @default.
• W1513821330 modified "2023-10-02" @default.
• W1513821330 title "Ganglioside GD2 as a therapeutic target for antibody-mediated therapy in patients with osteosarcoma" @default.
• W1513821330 cites W1901831739 @default.
• W1513821330 cites W1936567301 @default.
• W1513821330 cites W1947177866 @default.
• W1513821330 cites W1951179504 @default.
• W1513821330 cites W1963870450 @default.
• W1513821330 cites W1965605868 @default.
• W1513821330 cites W1966474027 @default.
• W1513821330 cites W1992018116 @default.
• W1513821330 cites W2007527741 @default.
• W1513821330 cites W2009420231 @default.
• W1513821330 cites W2030370920 @default.
• W1513821330 cites W2054551521 @default.
• W1513821330 cites W2058015212 @default.
• W1513821330 cites W2058138047 @default.
• W1513821330 cites W2062851784 @default.
• W1513821330 cites W2065347473 @default.
• W1513821330 cites W2089307156 @default.
• W1513821330 cites W2096336184 @default.
• W1513821330 cites W2112693092 @default.
• W1513821330 cites W2121146521 @default.
• W1513821330 cites W2122070299 @default.
• W1513821330 cites W2130465135 @default.
• W1513821330 cites W2141370466 @default.
• W1513821330 cites W2143634092 @default.
• W1513821330 cites W2149908785 @default.
• W1513821330 cites W2151310238 @default.
• W1513821330 cites W2171445183 @default.
• W1513821330 doi "https://doi.org/10.1002/cncr.28461" @default.
• W1513821330 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3946333" @default.
• W1513821330 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24166473" @default.
• W1513821330 hasPublicationYear "2013" @default.
• W1513821330 type Work @default.
• W1513821330 sameAs 1513821330 @default.
• W1513821330 citedByCount "122" @default.
• W1513821330 countsByYear W15138213302014 @default.
• W1513821330 countsByYear W15138213302015 @default.
• W1513821330 countsByYear W15138213302016 @default.
• W1513821330 countsByYear W15138213302017 @default.
• W1513821330 countsByYear W15138213302018 @default.
• W1513821330 countsByYear W15138213302019 @default.
• W1513821330 countsByYear W15138213302020 @default.
• W1513821330 countsByYear W15138213302021 @default.
• W1513821330 countsByYear W15138213302022 @default.
• W1513821330 countsByYear W15138213302023 @default.
• W1513821330 crossrefType "journal-article" @default.
• W1513821330 hasAuthorship W1513821330A5015087487 @default.
• W1513821330 hasAuthorship W1513821330A5032743242 @default.
• W1513821330 hasAuthorship W1513821330A5044457816 @default.
• W1513821330 hasAuthorship W1513821330A5052668402 @default.
• W1513821330 hasAuthorship W1513821330A5053864071 @default.
• W1513821330 hasAuthorship W1513821330A5055067235 @default.
• W1513821330 hasAuthorship W1513821330A5057392248 @default.
• W1513821330 hasAuthorship W1513821330A5064538521 @default.
• W1513821330 hasBestOaLocation W15138213302 @default.
• W1513821330 hasConcept C121608353 @default.
• W1513821330 hasConcept C126322002 @default.
• W1513821330 hasConcept C142724271 @default.
• W1513821330 hasConcept C159654299 @default.
• W1513821330 hasConcept C203014093 @default.
• W1513821330 hasConcept C204232928 @default.
• W1513821330 hasConcept C2775934546 @default.
• W1513821330 hasConcept C2776715637 @default.
• W1513821330 hasConcept C2777331542 @default.
• W1513821330 hasConcept C2777701055 @default.
• W1513821330 hasConcept C2777760704 @default.
• W1513821330 hasConcept C54355233 @default.
• W1513821330 hasConcept C55493867 @default.
• W1513821330 hasConcept C71924100 @default.
• W1513821330 hasConcept C74864618 @default.
• W1513821330 hasConcept C81885089 @default.
• W1513821330 hasConcept C86803240 @default.
• W1513821330 hasConceptScore W1513821330C121608353 @default.
• W1513821330 hasConceptScore W1513821330C126322002 @default.
• W1513821330 hasConceptScore W1513821330C142724271 @default.
• W1513821330 hasConceptScore W1513821330C159654299 @default.
• W1513821330 hasConceptScore W1513821330C203014093 @default.
• W1513821330 hasConceptScore W1513821330C204232928 @default.
• W1513821330 hasConceptScore W1513821330C2775934546 @default.
• W1513821330 hasConceptScore W1513821330C2776715637 @default.
• W1513821330 hasConceptScore W1513821330C2777331542 @default.
• W1513821330 hasConceptScore W1513821330C2777701055 @default.
• W1513821330 hasConceptScore W1513821330C2777760704 @default.
• W1513821330 hasConceptScore W1513821330C54355233 @default.
• W1513821330 hasConceptScore W1513821330C55493867 @default.
• W1513821330 hasConceptScore W1513821330C71924100 @default.

• next